A robust neuromuscular system protects rat and human skeletal muscle from sarcopenia

Aging

Volumn 8, Issue 4, 2016, Pages 712-728

  Pannérec, Alice ^a   Springer, Margherita ^a   Migliavacca, Eugenia ^a   Ireland, Alex ^b   Piasecki, Mathew ^b   Karaz, Sonia ^a   Jacot, Guillaume ^a   Métairon, Sylviane ^a   Danenberg, Esther ^a   Raymond, Frédéric ^a   Descombes, Patrick ^a   McPhee, Jamie S ^b   Feige, Jerome N ^a  

^a NESTLÉ RESEARCH CENTER   (Switzerland)

^b MANCHESTER METROPOLITAN UNIVERSITY   (United Kingdom)

Author keywords

Neuromuscular junction; Physical frailty; Sarcopenia; Skeletal muscle

Indexed keywords

TRANSCRIPTOME;

ADOLESCENT; ADULT; AGED; AGING; ANIMAL; FEMALE; GENE EXPRESSION; GENETICS; HUMAN; MALE; METABOLISM; MUSCLE ATROPHY; PATHOLOGY; PHYSIOLOGY; RAT; SARCOPENIA; SKELETAL MUSCLE; VERY ELDERLY; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; AGING; ANIMALS; FEMALE; GENE EXPRESSION; HUMANS; MALE; MUSCLE, SKELETAL; MUSCULAR ATROPHY; RATS; SARCOPENIA; TRANSCRIPTOME; YOUNG ADULT;

EID: 85003734540     PISSN: 19454589     EISSN: None     Source Type: Journal    
DOI: 10.18632/aging.100926     Document Type: Article

References (59)

1. Fielding RA, et al. Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia. J Am Med Dir Assoc. 2011; 12:249-256
2. Fried LP, Tangen CM, Walston J, Newman AB, Hirsch C, Gottdiener J, Seeman T, Tracy R, Kop WJ, Burke G, McBurnie MA, and Cardiovascular Health Study Collaborative Research G. Frailty in older adults: evidence for a phenotype. J Gerontol A Biol Sci Med Sci. 2001; 56:M146-156
3. Choi J, Ahn A, Kim S, and Won CW. Global Prevalence of Physical Frailty by Fried's Criteria in Community-Dwelling Elderly With National Population-Based Surveys. J Am Med Dir Assoc. 2015; 16:548-550
4. Morley JE, Anker SD, and von Haehling S. Prevalence, incidence, and clinical impact of sarcopenia: facts, numbers, and epidemiology-update 2014. J Cachexia Sarcopenia Muscle. 2014; 5:253-259
5. Ali S and Garcia JM. Sarcopenia, cachexia and aging: diagnosis, mechanisms and therapeutic options-a mini-review. Gerontology. 2014; 60:294-305
6. Barns M, Gondro C, Tellam RL, Radley-Crabb HG, Grounds MD, and Shavlakadze T. Molecular analyses provide insight into mechanisms underlying sarcopenia and myofibre denervation in old skeletal muscles of mice. Int J Biochem Cell Biol. 2014; 53:174-185
7. Capitanio D, Vasso M, De Palma S, Fania C, Torretta E, Cammarata FP, Magnaghi V, Procacci P, and GelfiC. Specific protein changes contribute to the differential muscle mass loss during ageing. Proteomics. 2016; 16:645-656
8. Ibebunjo C, et al. Genomic and proteomic profiling reveals reduced mitochondrial function and disruption of the neuromuscular junction driving rat sarcopenia. Mol Cell Biol. 2013; 33:194-212
9. Gonzalez-Freire M, de Cabo R, Studenski SA, and Ferrucci L. The Neuromuscular Junction: Aging at the Crossroad between Nerves and Muscle. Front Aging Neurosci. 2014; 6:208
10. Punga AR and Ruegg MA. Signaling and aging at the neuromuscular synapse: lessons learnt from neuromuscular diseases. Curr Opin Pharmacol. 2012; 12:340-346
11. Vandervoort AA. Aging of the human neuromuscular system. Muscle Nerve. 2002; 25:17-25
12. Delbono O. Neural control of aging skeletal muscle. Aging Cell. 2003; 2:21-29
13. Hepple RT and Rice CL. Innervation and neuromuscular control in ageing skeletal muscle. J Physiol. 2015 [Ahead of print]
14. Tomlinson BE and Irving D. The numbers of limb motor neurons in the human lumbosacral cord throughout life. J Neurol Sci. 1977; 34:213-219
15. McComas AJ. Motor unit estimation: anxieties and achievements. Muscle Nerve. 1995; 18:369-379
16. Roos MR, Rice CL, Connelly DM, and Vandervoort AA. Quadriceps muscle strength, contractile properties, and motor unit firing rates in young and old men. Muscle Nerve. 1999; 22:1094-1103
17. Ceballos D, Cuadras J, Verdu E, and Navarro X. Morphometric and ultrastructural changes with ageing in mouse peripheral nerve. J Anat. 1999; 195:563-576
18. Valdez G, Tapia JC, Kang H, Clemenson GD, Jr., Gage FH, Lichtman JW, and Sanes JR. Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc Natl Acad Sci U S A. 2010; 107:14863-14868
19. Rudolf R, Khan MM, Labeit S, and Deschenes MR. Degeneration of neuromuscular junction in age and dystrophy. Front Aging Neurosci. 2014; 6:99
20. Chai RJ, Vukovic J, Dunlop S, Grounds MD, and Shavlakadze T. Striking denervation of neuromuscular junctions without lumbar motoneuron loss in geriatric mouse muscle. PLoS One. 2011; 6:e28090
21. Tamaki T, Hirata M, and Uchiyama Y. Qualitative alteration of peripheral motor system begins prior to appearance of typical sarcopenia syndrome in middle-aged rats. Front Aging Neurosci. 2014; 6:296
22. Piasecki M, Ireland A, Stashuk D, Hamilton-Wright A, Jones DA, and McPhee JS. Age-related neuromuscular changes affecting human vastus lateralis. J Physiol. 2015
23. Tintignac LA, Brenner HR, and Ruegg MA. Mechanisms Regulating Neuromuscular Junction Development and Function and Causes of Muscle Wasting. Physiol Rev. 2015; 95:809-852
24. Ravel-Chapuis A, Vandromme M, Thomas JL, and Schaeffer L. Postsynaptic chromatin is under neural control at the neuromuscular junction. EMBO J. 2007; 26:1117-1128
25. Mejat A, Ravel-Chapuis A, Vandromme M, and Schaeffer L. Synapse-specific gene expression at the neuromuscular junction. Ann N Y Acad Sci. 2003; 998:53-65
26. Lacazette E, Le Calvez S, Gajendran N, and Brenner HR. A novel pathway for MuSK to induce key genes in neuromuscular synapse formation. J Cell Biol. 2003; 161:727-736
27. Mejat A, Ramond F, Bassel-Duby R, Khochbin S, Olson EN, and Schaeffer L. Histone deacetylase 9 couples neuronal activity to muscle chromatin acetylation and gene expression. Nat Neurosci. 2005; 8:313-321
28. Ballak SB, Degens H, de Haan A, and Jaspers RT. Aging related changes in determinants of muscle force generating capacity: a comparison of muscle aging in men and male rodents. Ageing Res Rev. 2014; 14:43-55
29. Lexell J, Taylor CC, and Sjostrom M. What is the cause of the ageing atrophy? Total number, size and proportion of different fiber types studied in whole vastus lateralis muscle from 15-to 83-year-old men. J Neurol Sci. 1988; 84:275-294
30. Cruz-Jentoft AJ, et al. Sarcopenia: European consensus on definition and diagnosis: Report of the European Working Group on Sarcopenia in Older People. Age Ageing. 2010; 39:412-423
31. Deschenes MR. Motor unit and neuromuscular junction remodeling with aging. Curr Aging Sci. 2011; 4:209-220
32. Valdez G, Tapia JC, Lichtman JW, Fox MA, and Sanes JR. Shared resistance to aging and ALS in neuromuscular junctions of specific muscles. PLoS One. 2012; 7:e34640
33. Feng X, Zhang T, Ralston E, and Ludlow CL. Differences in neuromuscular junctions of laryngeal and limb muscles in rats. Laryngoscope. 2012; 122:1093-1098
34. Nave KA and Werner HB. Myelination of the nervous system: mechanisms and functions. Annu Rev Cell Dev Biol. 2014; 30:503-533
35. Saher G, Quintes S, and Nave KA. Cholesterol: a novel regulatory role in myelin formation. Neuroscientist. 2011; 17:79-93
36. Saher G and Stumpf SK. Cholesterol in myelin biogenesis and hypomyelinating disorders. Biochim Biophys Acta. 2015. 1851:1083-1094
37. Ibanez CF and Simi A. p75 neurotrophin receptor signaling in nervous system injury and degeneration: paradox and opportunity. Trends Neurosci. 2012; 35:431-440
38. Abe T, Sakamaki M, Yasuda T, Bemben MG, Kondo M, Kawakami Y, and Fukunaga T. Age-related, site-specific muscle loss in 1507 Japanese men and women aged 20 to 95 years. J Sports Sci Med. 2011; 10:145-150
39. Maden-Wilkinson TM, McPhee JS, Rittweger J, Jones DA, and Degens H. Thigh muscle volume in relation to age, sex and femur volume. Age (Dordr). 2014; 36:383-393
40. Piasecki M, Ireland A, Jones DA, and McPhee JS. Agedependent motor unit remodelling in human limb muscles. Biogerontology. 2015
41. Janssen I, Heymsfield SB, Wang ZM, and Ross R. Skeletal muscle mass and distribution in 468 men and women aged 18-88 yr. J Appl Physiol (1985). 2000; 89:81-88
42. Batt J, Bain J, Goncalves J, Michalski B, Plant P, Fahnestock M, and Woodgett J. Differential gene expression profiling of short and long term denervated muscle. FASEB J. 2006; 20:115-117
43. O'Leary MF, Vainshtein A, Carter HN, Zhang Y, and Hood DA. Denervation-induced mitochondrial dysfunction and autophagy in skeletal muscle of apoptosis-deficient animals. Am J Physiol Cell Physiol. 2012; 303:C447-454
44. Raffaello A, Laveder P, Romualdi C, Bean C, Toniolo L, Germinario E, Megighian A, Danieli-Betto D, Reggiani C, and Lanfranchi G. Denervation in murine fast-twitch muscle: shortterm physiological changes and temporal expression profiling. Physiol Genomics. 2006; 25:60-74
45. Vainshtein A, Desjardins EM, Armani A, Sandri M, and Hood DA. PGC-1alpha modulates denervation-induced mitophagy in skeletal muscle. Skelet Muscle. 2015; 5:9
46. Verdier V, Csardi G, de Preux-Charles AS, Medard JJ, Smit AB, Verheijen MH, Bergmann S, and Chrast R. Aging of myelinating glial cells predominantly affects lipid metabolism and immune response pathways. Glia. 2012; 60:751-760
47. Hashizume K and Kanda K. Differential effects of aging on motoneurons and peripheral nerves innervating the hindlimb and forelimb muscles of rats. Neurosci Res. 1995; 22:189-196
48. Hourigan ML, McKinnon NB, Johnson M, Rice CL, Stashuk DW, and Doherty TJ. Increased motor unit potential shape variability across consecutive motor unit discharges in the tibialis anterior and vastus medialis muscles of healthy older subjects. Clin Neurophysiol. 2015; 126:2381-2389
49. Saher G, Brugger B, Lappe-Siefke C, Mobius W, Tozawa R, Wehr MC, Wieland F, Ishibashi S, and Nave KA. High cholesterol level is essential for myelin membrane growth. Nat Neurosci. 2005; 8:468-475
50. Verheijen MH, et al. SCAP is required for timely and proper myelin membrane synthesis. Proc Natl Acad Sci U S A. 2009; 106:21383-21388
51. Gaist D, Jeppesen U, Andersen M, Garcia Rodriguez LA, Hallas J, and Sindrup SH. Statins and risk of polyneuropathy: a case-control study. Neurology. 2002; 58:1333-1337
52. Stroes ES, et al. Statin-associated muscle symptoms: impact on statin therapy-European Atherosclerosis Society Consensus Panel Statement on Assessment, Aetiology and Management. Eur Heart J. 2015; 36:1012-1022
53. McGeachie AB, Koishi K, Imamura T, McLennan IS, Department of A, and Structural Biology UoODNZ. Fibroblast growth factor-5 is expressed in Schwann cells and is not essential for motoneurone survival. Neuroscience. 2001; 104:891-899
54. Greising SM, Ermilov LG, Sieck GC, and Mantilla CB. Ageing and neurotrophic signalling effects on diaphragm neuromuscular function. J Physiol. 2015; 593:431-440
55. Scarlato M, Xu T, Bannerman P, Beesley J, Reddy UR, Rostami A, Scherer SS, and Pleasure D. Axon-Schwann cell interactions regulate the expression of fibroblast growth factor-5 (FGF-5). J Neurosci Res. 2001; 66:16-22
56. Berthold M, Cebron N, Dill F, Gabriel T, Kötter T, Meinl T, Ohl P, Sieb C, Thiel K, and Wiswedel B, KNIME: The Konstanz Information Miner, in Data Analysis, Machine Learning and Applications C. Preisach, et al. Editors. 2008, Springer Berlin Heidelberg. p. 319-326
57. Smyth GK. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. 2004; 3:Article3
58. Law CW, Chen Y, Shi W, and Smyth GK. voom: Precision weights unlock linear model analysis tools for RNA-seq read counts. Genome Biol. 2014; 15:R29
59. Smyth GK, Michaud J, and Scott HS. Use of within-array replicate spots for assessing differential expression in microarray experiments. Bioinformatics. 2005; 21:2067-2075